Sun. Sep 15th, 2019

Breaking News

Pediatric Vaccine Market Is Expected To Reach Around USD $56.28 Billion By 2025

(MENAFN – Zion Market Research) Zion Market Research has published a new report titled ‘Pediatric Vaccine Market By Vaccine Type (Monovalent and Multivalent), By Administration Method (Oral, Intramuscular, and Subcutaneous), By Disease Type (Meningococcal Disease, Hepatitis, Influenza, Polio, Pneumococcal Disease, DTP, MMR, Dengue, Rotavirus, HPV, Varicella, Herpes Zoster, and Others), By Technology (Recombinant Vaccines, Inactivated Vaccines, Conjugate Vaccines, Toxoid Vaccines, and Live Attenuated Vaccines), and By End-User (Hospitals, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 20182025. According to the report, the global demand for pediatric vaccine market was approximately USD 27.45 billion in 2018 and is expected to generate around USD 56.28 billion by 2025, at a CAGR of around 10.8% between 2019 and 2025. Read more: https://menafn.com/1098868665/Pediatric-Vaccine-Market-Is-Expected-To-Reach-Around-USD-5628-Billion-By-2025

Human Tissue in Vaccines

Vaccinating with human body parts can cause the recipient to produce antibodies to human tissue. Children produce antibodies to every component of the vaccine, and not simply the viruses. This can cause demylination of the nerves and auto-immune disorders. Children who have been vaccinated with MMR and later suffered autism have been found to have antibodies to their own brain tissue, and this may be a consequence of using foetal tissue in MMR. ‘Susana C. Silva, Catarina Correia and Astrid M. Vicente at the Instituto Gulbenkian de Ciência, Oeiras, Portugal and colleagues studied the blood of a large sample of individuals – 171 patients, 191 parents and 54 healthy controls – and report that autistic patients are in fact characterised by presenting in their blood high levels of non-inherited antibodies against the body’s brain tissue.’ (Dr Catarina Amorim; Journal of Neuroimmunology; Instituto Gulbenkian de Ciência, Observatório da Ciência e do Ensino Superior, Portugal; July 23, 2004)

 

Comments are held for moderation and your email will NOT be used for Spam. Troll comments not accepted so don’t waste your time.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: